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- 3  -PRESENTATION  OF  AN  APPLICATION  FOR  ASSESSMENT  OF  A 
FOOD  ADDITIVE  PRIOR  TO  ITS  AUTHORISATION 
1.  INTRODUCTORY  REMARKS 
(i)  The  admission  of  a  substance  as  food  additive is dependent 
on  the availability of  experimental  data,  on  which  an 
objective evaluation of  the material's safety  can  be  made. 
Cii)  Irrespective of  whether  the additive  is on  a  Community  list 
or  simply  subject  to national  rules  each  Member  State 
evaluates its safety - firstly,  in terms  of  its 
acceptability  in general  and  secondly,  in terms  of  the 
conditions of  use  within its territory. 
(iii)  Where  the  addition of  a  substance to a  Community  list is 
concerned,  the  Commission  consults  the  EEC  Scientific 
Committee  for  Food,  an  independent  group  of  scientists drawn 
from  the  Members  States with  knowledge  of  food  safety 
matters,  prior to the  submission of its proposals. 
Civ)  Member  States must  also be  mindful  of  the  safety  in use  of  a 
particular additive  in  the  context  of  its national 
consumption  patterns and  each  State  has  its own  particular 
system  of  evaluation. 
2.  FORMAT  OF  THE  DOSSIER 
(i)  The  format  and  contents of  a  dossier  as  described  in  Annex  I 
have  been  devised  by  a  working  party  composed  of government 
experts,  the  Scientific Committee  for  Food  and  the 
Commission  services  as  acceptable for  an  application for  the 
assessment  of  food  additives.  Other  formats  may  also be 
acceptable  to  individual  authorities.  Other  legal 
prov1s1ons  concerning  applications  should  be  discussed  with 
the  competent  services. 
Cii)  It is  likely that  the  "EEC"  dossier will  be  the  most 
comprehensive  as  this takes  into account  the particular 
concerns  of  each  Member  State. 
(iii)  Applicants  should discuss  with  individual  Member  States or 
the  Commission  any  special  submissions  for  which  the extent 
of  information  in  a  particular dossier is  less  than 
described.  During  the evaluation of  a  dossier,  further 
justified requests  by  the  responsible authority for 
additional  testing cannot  be  excluded if such  tests are 
necessary to assess  the  significance of  the effects found. 
- 5  -It  would  be  expected  that  such  tests would,  as  far  as 
possible,  be  presented  in the  same  format  as  the  initial 
studies. 
3.  RESPONSIBLE  AUTHORITIES 
Dossiers  for  evaluation by  Member  States and  the  Commisison  must 
be  submitted to  the  responsible authority<ies)  listed  in  Annex  II. 
4.  OTHER  REQUIREMENTS 
Individual  responsible authorities  have  differing  requirements 
for  the  number  of  copies of dossier  and  summaries.  These  are 
specified  in  Annex  III. 
- 6  -ANNEX  I 
DOSSIER 
PART  I.  ADMINISTRATIVE  DATA 
I.1.  The  name  of  the  applicant  (firm,  organisation, etc.), address 
and  other means  of  communication,  e.g.  telex,  telephone. 
I.2.  The  name  of  the  manufacturer(s)  of  the  substance  Cif  different), 
address  and  other means  of  communication,  e.g.  tele_x,  telephone. 
I.3.  The  name  of  the person  responsible  for  the dossier. 
I.4.  The  table of  contents  of  the dossier. 
Where  the dossier differs from  similar dossiers  sent  to  individual 
Member  States  by  the applicant,  this  should  be  indicated. 
PART  II.  TECHNICAL  DATA 
II.1.  Name  of the substance 
- names  in the  IUPAC  nomenclature; 
- other names  (usual  name,  trade  name,  synonyms,  abbrevations>; 
- CAS  number  (if this has  been  attributed). 
II.2.  Specification of the substance 
composition  C%,  w/v,  mg/kg),  e.g.  in  the  case of 
heterogeneous  products>; 
-empirical and  structural  formula; 
- molecular  weight; 
- degree  of  purity  C%>; 
- nature of  known  impurities; 
percentage of  significant  and  main  impurities; 
-physical  form  (liquid,  powder,  etc.>; 
-solubility (e.g.  aqueous,  organic  solvents,  lipid>; 
-other data  that  the  applicant  believes  may  be  useful  to 
identify the  substance  (e.g.  physico-chemical  properties, 
analytical data  on  differences  between  batches>,* 
*Applicants are  referred to  Council  Directive  79/831/EEC,  amending 
for  the  sixth  time  Directive  No  67/548/EEC,  on  the  approximation  of 
laws  regulations  and  administrative provisions  relating to  the 
classification, packaging  and  labelling of  dangerous  substances 
(OJ  L 259  of  15.10.79,  p.  10),  in particular  Annex  VII  thereof. 
- 7  -- information on  the microbiological  characteristics,  in 
particular on  the  possible presence of  pathogens  and 
bacterial or myco-toxins. 
11.3.  Manufacturing  process 
-information on  the method  of  manufacture  (i.e.  the  process  by 
which  the  raw  materials  are  converted to the  finished 
product). 
Factors  such  as  reaction  sequence,  side  reactions,  purification 
and  preparation of  the  product  to be  commercialized assist  in 
determining  likely impurities and  their unfluence on  the 
toxicological  evaluation. 
11.4.  Methods  of analysis 
- analytical  methods  to describe the  substance,  evaluate its 
purity and  measure  its physico-chemical  and  microbiological 
characteristics; 
- analytical  methods  for  the determination of the additive and 
its degradation  products  <where  relevant),  in  the  foodstuff 
of  which  the  substance  is to  form  part. 
Where  the  methods  used  are specified  in Part  A of  Commission 
Directive 84/449/EEC  of  25  April  1984  on  the  approximation of 
laws,  regulations  and  administrative provisions  relating to the 
classification, packaging  and  labelling of dangerous  substances 
{OJ  L 251  of  19.9.1984,  p.  1>,  these  may  be  given  by  reference 
only.  Other  methods  should  be  given  in full  unless  they  are 
sufficiently well  described  in scientific  literature to  make 
this  unnecessary. 
11.5.  Justification for the additive 
- intended use  and  purpose; 
- the quantity to be  added  to specific  foods  and  the  residues 
in  food; 
- investigations on  the efficacy of  the  substance  for  the 
intended effect at  the  level  proposed; 
- documentation  on  the  need  for  the additive;  benefit  for  the 
consumer. 
A summary  of  basic principles is  included as  Annex  IV 
11.6.  Exposure 
- likely  human  exposure  <actual  or  expected)  from  food  and 
other  sources,  including  route,  frequency,  duration  and  other 
factors  influencing exposure  <e.g.  maximum  and  average  dosage 
or  exposure>; 
- 8  -- consumption  of  the  food  including variations affecting 
particular sections of  the  population  (e.g.  by  age,  sex, 
disease  or occupation). 
Information  on  national authorisations  (within or outside the 
Community)  with  indication of  levels  in  the  food  in which  the 
substance  is used  gives  useful  guidance  on  possible exposure. 
II.7.  Reaction and  fate  in food 
- any  significant degradation  products or  reaction products 
appearing  as  a  result  of  the  storage and  preparation of  food 
with  the additive; 
- any  possible effect on  nutrients. 
PART  III.  TOXICOLOGICAL  DATA 
III.1.  General  principles for  the  to~:icological evaluation of food 
additives 
If  the  technological  need  and  value to  consumer  of  a  food 
additive  have  been  established, it is necessary  to evaluate 
the  implications  for  the  health of  the  consumer  due  to the 
presence of that  additive  in  food.  It  is necessary  to 
determine  by  toxicological  examination  whether  the  substance, 
when  used  in  the manner  and  in  the quantities proposed,  might 
be  injurious to the  health of  those population groups  whose 
pattern of  food  consumption' or  physiological  status makes  them 
most  vulnerable, e.g.  age,  pregnancy.  No  fixed  programme  is 
Laid  down  to  be  followed  rigidly  in every  case,  but  a 
framework  is summarized  for  planning  a  sequence  of  steps  which 
enables  the  safety-in-use of  a  food  additive to be  evaluated. 
It  may  be  possible to use  human  data derived  from  medical  use, 
occupational  epidemiology,  or specific studies,  such  as 
studies  on  volunteers or on  critically exposed  groups,  but  in 
general, one  must  rely  on  experimental  data derived  from 
investigations  in  Laboratory  animals.  If the biological 
action of  a  substance  has  been  ascertained qualitatively and 
quantitatively  in different  laboratory  animals,  the  Likely 
effects on  man  can  then  be  estimated by  careful  extrapolation. 
Studies will  be  requested  in their entirety or  in part 
depending  on  the  nature of  the additive and  on  the  conditions 
proposed  for  its use. 
In  general, this text  is  intended to apply  to the  evaluation 
of  new,  or  the  re-evaluation of  already  established 
intentional  food  additives, directly  incorporated  into food 
and  fulfilling  a  defined  purpose. 
The  reasons  for  carrying out  unusual  studies should  be  stated, 
as  should  the  reasons,  for  not  submitting  a  study  of  a  type 
that  might  be  expected. 
- 9  -All  the  important  results obtained,  favourable  or 
unfavourable,  should  be  presented  with  the  full  original  data 
to  allow  a  critical appreciation,  independent  of  the 
interpretation of  the  author. 
As  specified tests are  completed,  the  toxicologist  might 
decide  that  a  decision on  safety  can  already  be  taken  in the 
light of  the  results obtained.  However,  in principle, it is 
desirable that  any  food  additive  should be  fully  examined  for 
all  toxicological potentialities before  its safety-in-use  can 
be  accepted. 
111.2.  Protocols 
Methods  for  determining toxicity are described  in  Commission 
Directive 84/449/EEC  of  25  April  1984,  adapting  to technical 
progress  for  the  sixth  time,  Council  Directive 67/548/EEC  on 
the  approximation  of  laws,  regulations  and  administrative 
provisions  relating to  the classification,  packaging  and 
labelling of  dangerous  substances  (OJ  L 251  of  19.9.1984, 
p.1). 
Protocols  for  undertaking  studies  have  also  been  developed  in 
many  international  fora  <e.g.  WHO,  OECD).  Test  requirements 
are  always  subject  to  review,  and  discussion  with  regulatory 
authorities  is  recommended. 
The  use  of other methods  should  be  justified. 
To  ensure the mutual  recognition  by  Member  States of  the data 
submitted,  studies  should  be  carried out  according  to the 
principles of  Good  Laboratory  Practice,  described  in  Council 
Directive 87/18/EEC  of  18  December  1986.  {OJ  No  L 15  of 
17.1.1987,  p.  29).  Adequate  explanation  must  be  provided  for 
divergences  from  these  principles. 
Attention  is also drawn  to  the  Council  Directive 86/609/EEC  of 
24  November  1986  {OJ  No  L 358  of  18.12.1986,  p.  1)  on  the 
protection of  animals  used  for  experimental  and  other 
scientific  purposes. 
111.3.  Toxicological  section of the dossier 
The  toxicological  section of  the dossier  should  comprise 
sections as  follows. 
<a>  Acute  toxicity 
Range-finding  studies  provide  information on  dosage  for 
feeding  studies  and  target  organs. 
- 10  -\ 
(b)  Genetic  toxicity 
It  is  recommended  that  any  new  food  additive should  be 
investigated for  mutagenic  potential  by  testing procedures 
which  _cover  both  gene  and  chromosome  damage,  both  in vitro 
and  in vivo. 
In  this way,  some  evidence  may  be  provided  upon  which  a 
preliminary  assessment  of  a  possible mutagenic  hazard  can 
be  based.  This  information will  be  helpful  in setting 
priorities for  long-term testing. 
(c)  Metabolic,  including pharmacokinetic  studies  (alternative 
terms are toxicokinetics or chemobiokinetics> 
These  studies are  carried out  principally to gain  an 
understanding of  the  absorption,  biotransformation, 
disposition and  elimination of-an  ingested foreign 
substance after a  single and  repeated doses.  They  also 
provide  information about  the  rate at  which  these 
processes occur  and  the  temporal  relationship between  dose 
and  tissue  levels  reached. 
The  information obtained assists 
- in planning studies  in  laboratory animals; 
in selecting the  species, dosing  regime  and  duration of 
studies; 
- in assessing the  relative importance  of different 
metabolic  pathways; 
- in assessing the  relationship of  species differences to 
the  likely metabolism  in  man; 
- in assessing the extent  of and  even  the  need  for 
extensive toxicological  testing, e.g.  non-absorbed 
compounds,  metabolism  to normal  body  constituents. 
In  vitro preliminary studies on  the effects of  acids, 
bas~s and  hydrolytic  enzymes  may  be  followed  by 
investigation of  the  biodegradation  in the gut,  of  the 
transformation  by  tissue cells or  perfused organs.  The 
capacity to  form  chemically  reactive metabolites  is a  key 
information for  the  understanding of  the toxic effects, 
species differences  and  reactions  with  the genetic 
material.  The  possibility of  enzyme  induction  and  the 
determination of  major  and  minor  metabolites are also 
essential  as  is the  assessment  of  the possibility of 
placental  transfer. 
<d>  Subchronic  studies 
Studies  in  two  laboratory  species  <usually  a  rodent  and  a 
non-rodent)  are  normally  required,  generally  representing 
10%  of  the  life span  of  the  species selected. 
- 11  -The  major  objective of  subchronic  studies  is the 
establishment  of  the  spectrum  of  toxicological effects of 
the  compound,  their nature  and  severity  in an  animal 
species  in  which  the metabolic  pathways  of  the  same  or 
analogous  substances  are as  similar as  possible to those 
in man. 
<e>  Reproduction  and  teratogenicity studies 
The  purpose  of  reproduction  studies is to  provide 
information  about  the possible  increase,  in successive 
generations,  in sensitivity to  a  substance,  the effects on 
the fertility of  male  and  female  animals,  the detection of 
any  pre-, peri- and  post-natal effects on  the  embryo,  the 
foetus,  and  the young,  including any  teratogenic  and 
mutagenic  effects,  and  the discovery  of  peri- and 
post-natal effects on  the mother. 
Food  additives  should  be  tested for  teratogenicity  in at 
least  two  species.  The  practical possibilities are  the 
mouse,  rat  or  rabbit;  in certain circumstances,  the 
hamster  and  the  guinea-pig  may  be  more  appropriate. 
(f)  Chronic  toxicity studies and  carcinogenicity studies 
For  food  additives it is  recommended  that  combined 
protocols  be  used  for  studying  chronic  toxicity and 
carcinogenicity in  the  same  experiment.  Most  of  the 
procedures  for  carrying out  such  chronic  studies are 
relatively standardized but  several  areas  are still 
considered  controversial.  The  selection of  te~t species 
is  limited by  many  practical  considerations,  although  the 
animal  model  should  be  biologically appropriate  for  the 
toxicological  assessment  of  the possible  human  risk.  This 
implies  that  metabolism  and  pharmacokinetics of  the  test 
substance  in the  species  and  strains chosen  should mimic 
those  in  man  as  closely as  possible.  For  food  additives 
both  mice  and  rats are the traditional  species  employed 
because  of  the  relatively short  life span,  size,  cost  and 
extensive experience  and  availablity of  information on 
their biological  characteristics.  Both  species  have  to be 
used  in  most  circumstances  unless  specific considerations 
dictate otherwise.  Dogs  and  non-human  primates  may  be 
useful  when  the nature of  the toxicity or  the  procedures 
required necessitate  the  use  of  large  species. 
(g)  Allergic,  intolerant and  other idiosyncratic  reactions 
At  present  there exist  no  validated methods  for  studies  in 
animals  which  allow  assessment  of  an  additive's potential 
for  causing  intolerant  and/or  allergic  reactions  in 
susceptible  individuals  following  oral  exposure.  However 
studies  relevant  to dermal  <contact)  and  inhalational 
- 12  -sensitiation can  be  performed.  These  studies  may  give 
information  relevant  to occupational  exposure,  and  could 
be  helpful  in assessing  consumer  safety.  As  techniques 
for  such  studies vary  considerably,  the  reasons  for  using 
the particular method(s)  should  be  explained  (also  in the 
summary). 
Human  studies  (see below)  or other  human  experience,  such 
as  pre-marketing  surveys,  may  give  some  information  about 
idiosyncratic  reactions  to a  new  food  additive.  Although 
data  may  be  limited due  to  a  small  number  of  subjects 
involved,  all exposed  subjects  should  be  monitored  for 
possible  idiosyncratic actions,  and  any  data  (positive or 
negative)  should  be  included  in the dossier. 
<h>  Human  studies 
When  the  safety of  a  new  addditive  has  been  adequately 
demonstrated  in animals,  clinical studies  in  volunteers 
may  be  undertaken.  Such  studies are particularly useful 
in providing pharmacokinetic  and  metabolic  data,  but  other 
special  studies  in  humans  may  sometimes  be  appropriate. 
Any  studies must  satisfy the ethical  requirements  for 
investigation  in  humans,  and  several  national  and 
international guidelines on  this subject  have  been 
published. 
In  addition to clinical studies any  available  information 
should  be  presented on  observations  in  humans  made  during 
the  use  of  a  food  additive  in a  third country,  in 
pre-marketing trials, as  a  result of  occupational  exposure 
or  following  accidental or deliberate poisoning. 
III.4.  Data  reporting for the toxicological section 
The  data  reported  for  each  study  in the  toxicological  section 
of  the dossier  should  as  far  as  possible  follow  the  sequence 
summarized  below. 
<a>  Laboratory diet and  husbandry 
- a  full  description of  the  animal  diet  used  in the 
biological studies,  including  composition,  the  results 
of  analyses  for  macro- and  micro-nutrients,  presence  or 
absence  of  toxicologically  important  contaminants  <e.g. 
myco-toxins,  toxic  heavy  metals, etc.); 
- conditions of  husbandry,  distribution and  environmental 
circumstances. 
- 13  -(b)  Experi•ental design 
(i)  Material  tested 
-analytical data  on  the  batch  used  should  be 
provided  if the  specification  is  different  from 
that  given  in  Part II <e.g.  technical grade  rather 
than  food  grade),  the  differences  should  be 
identified,  the  reasons  explained  and  the 
significance  discussed. 
( i i )  An i rna l s 
- species,  strains, microbiological  status, sex, 
random  allocation to groups,  group  sizes,  age 
and/or  weight  at  the  start of  the  study,  type  of 
diet,  anti-microbial  agents,  other  drugs  or 
vaccines  administered. 
<iii)  Compound  preparation  and  administration 
- route,  duration,  frequency,  dosage  (by  volume  as 
well  as  concentration  for  liquids),  estimated 
total doses  (for  long-term  studies),  controls 
(positive  and  negative)  and  vehicle. 
<iv)  Duration  of  study  if different  from  duration  of 
dosage. 
(v)  Any  unusual  study  design  considerations  such  as 
paired  feeding,  satellite groups  or  interim kills 
should  be  noted. 
(vi)  Nature  of  major  observations 
- frequency  of  body  weight  measurement,  timing, 
volume  and  site  of  blood  sampling,  timing  of "urine 
collection,  haematological  and  clinical  chemistry 
parameters  measured,  methods  of  killing  animals, 
organs  weighed,  organs  examined 
macroscopically/microscopically,  methods  of 
examining  foetuses,  etc. 
(vii)  Statistical  analyses  employed 
- specify methods  used  including  reference  to 
publication  of  any  new  or  unusual  statistical 
tests used. 
- 14  -<c>  Results 
The  main  findings  should  be  summarized  and  a  statement 
made  on  whether  significant deviations  from  control  and 
normal  values  occured. 
(i)  Clinical  condition 
- general  health,  intercurrent disease,  behaviour 
(including the  results of  specific observations, 
if undertaken>,  clinical  investigations  <including 
opthalmoscopic  findings,  palpitation). 
(ii)  Mortality 
- times  of death  and  causes,  where  known. 
(iii)  Weight  change,  food  and  water  consumption, 
relationship of  growth  rates to dosage  and  to any 
changes  in  food  consumption/utilisation. 
(iv)  Haematology 
- haemoglobin  concentration and  red  cell parameters, 
white  blood  cell  count  and  differential; other 
haematological  parameters  where  appropriate. 
<v>  Clinical  chemistry 
-urea and  electrolytes, glucose,  liver function 
tests and  routine urinalysis; other clinical 
chemistry studies  where  appropriate. 
<vi)  Pathology 
-macroscopic  abnormalities observed at  post-mortem 
examinations  and  abnormalities  on  histological 
examination  should  be  described.  In  addition to 
the  current  control  incidence of  lesions,  the 
background  incidence  may  need  to be  given,  e.g. 
the  incidence  of  tumours  in  control  groups  in 
other  experiments  carried out  in the  same  strain 
and  sex  at  a  similar  time  <concurrent  controls)  or 
in  the  past  (historical  controls>.  This  is of 
particular  importance  when  it appears  that  the 
current  control  data  are atypical.  Where  special 
studies  <histochemistry,  electron microscopy  or 
quantitative histology)  have  been  undertaken,  the 
findings  should  be  described  in  relation to those 
from  routine histology.  In  the  study  summary,  the 
information  should  be  clearly presented  in  a 
concise  form. 
- 15  -The  significant  findings  from  the  study  should  be 
highlighted  together  with  the  no-adverse-effect  level,  if 
one  has  been  determined,  and  any  other  relevant 
information. 
<e>  Reference 
<i>  published data 
Author,  journal,  and  date. 
(ii)  unpublished  data 
Applicant,  investigator,  laboratory and  date. 
111.5.  Review  of results and  conclusions 
PART  IV. 
The  section should  list all significant  findings  in all 
studies and  seek  to make  interpretations and  draw  conclusions, 
which  the submitter  would  wish  the  Commission/national 
administration to  consider.  The  reasons  for  disregarding  any 
findings  should  be  carefylly explained.  Where  relevant, 
attention may  be  drawn  to  the  extent  to which  dosage  or 
concentrations  are exaggerated  and  the possible  influence of 
the vehicle  used  for  administering  the  substance.  The 
conclusion  should  include  an  interpretation of  the 
significance of  the  finding  in  terms  of  possible mechanisms  of 
the effect  seen  in the  animal  and  extrapolation of the animal 
data  to  humans.  References  to  known  effects  <or  lack  of 
effect)  in  human  exposure  should  be  given;  evidence  from 
recorded  experience  for  occupational  exposure,  for  example, 
may  be  informative.  The  evaluation of  potential  human  hazard 
should  be  made  in  the  context  of  known  or  likely  human 
exposure,  including that  from  other  sources. 
SUMMARY  DOCUMENT 
The  summary  should  follow  the  same  order as  decribed  for  the dossier. 
Parts  I  and  II need  only  be  completed  once  for  each  substance or 
product.  A summary  should  be  completed  for  each  study  reported  in the 
toxicological  section of  the dossier. 
The  main  findings  should  be  summarized  and  a  statement  made  on  whether 
significant deviations  from  control  and  normal  values  occured. 
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BELGIQUE/BELGIE 
Inspection  des  denrees  alimentaires 
Ministere  de  La  Sante  Publique 
Cite  Administrative  de  l'Etat 
Quartier Vesale 
B-1010  Bruxelles 
Telex 
TeL 
Tele fax 
DANMARK 
25768  MUGSP 
32  2  210  48  57 
32  2  218  67  46 
Levnedsmiddelstyrelsen,  2.  kontor 
M0rkh0j  Bygade  19 
DK-2860,S0borg 
Telex 
Tel 
TeL efax 
16298  FOODIN  OK 
45  31  69  66  00 
45  31  69  61  26 
BUNDESREPUBLIK  DEUTSCHLAND 
ANEXO 
II 
Bundesmi nisterium  fur  Jugend,  Fami Lie  und 
Gesundheit 
Kennedy a llee 105-1 07 
D-5300  Bonn  2 
TeLex 
Tel 
Te Lefax 
ELLAS 
885517/885437 
49  2  28  30  83  204 
49  2  28  30  82  221 
Laboratoire Generale  de  Chimie  de  L'Etat 
Direction  des  Applications  Chimiques 
Avenue  Tsokha  16 
GR-602  ATHENS 
Telex  218311 
Tel  30  1  642  82  11 
Te Lef ax 
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Ministerio de  Sanidad  y  Consume 
Direcci6n  General  de  Salud  Alimentaria  y  Proteccion 
de  Los  Consumidores 
Paseo  deL  Prado,  18-20 
E-28014  Madrid 
TeLex 
Tel 
22608  MSASS  E y  44014  MSASS  E 
34  1  227  54  47 
TeL efax  34  1  239  40  69 
FRANCE 
Ministere de  L'Economie,  des  Finances  et  de  La 
Pr i vat i s at i on 
Direction Generale  de  La  Concurrence,  de  La 
Consommation  et  de  La  Repression  des  Fraudes 
(D.G.C.C.R.F.). 
Bureau  H2 
13,  rue  St  Georges 
F-75436  Paris  Cedex  09 
Telex 
TeL 
Telefax 
IRELAND 
643910  FIREP 
3  3  1  42  8  5  1  3  50 
33  1~ 42  80  47  66 
Public  Health  Division 
Department  of  Health 
Hawkins  House 
Dublin  2 
33451  HLT  EI  TeLex 
TeL  353  1  71  47  11  Ext.  570,  590,  588 
Te Lefax 
IT ALIA 
M  i n i s t e ro  de L  L  a  san i ta 
D.G.  Igiene  Alimenti 
e  Nutrizione 
Piazza  Marconi  25 
(Pal.  Italia) 
I-Q0144  Roma 
TeLex 
TeL 
Te Lef ax 
613169 
39  6  59  94 
39  6  59  24  774 
- 20  -LUXE IVI3 OU RG 
Ministere de  La  Sante 
1A,  rue  Auguste  Lumiere 
L-2935  Luxembourg 
Telex 
Tel 
Telefax 
NEDERLAND 
2546  SANTE  LU 
35  2  48  83  65 
Het  Ministerie  van  Welzijn,  Volkgezondheid  en  Cultuur 
Di rekt i e  VVP 
Postbus  5406 
NL-2280  HK  Rijswijk 
Telex 
Tel 
Telefax 
PORTUGAL 
31680  WVCRW  NL 
31  70  40  79  11 
31  70  20  17  03 
Institute de  Qualidade  Alimentar 
Secretaria  de  Estado  da  Alimenta~ao 
Ministerio da  Agricultura,  Pescas  e  Alimenta~ao 
Rua  Alexandre  Herculano  6  - 4° 
P  - 11 00  L i sb oa 
62320  IQA  P  Telex 
TeL  Geral  351  1  52  91  86/7/8/9 
Presidente 351  1  54  83  06 
Te Lef ax  551  1  54  94  51 
UNIT ED  KINGDOM 
Administrative Secretary 
Food  Advisory  Committee 
Ministry  of  Agriculture 
Fisheries and  Food, 
3068  Ergon  House,  c/o  Nobel  House 
Smi th  Square  17 
UK-SW1P  3JR  LONDON 
Telex  21271  MAFWSL  G 
Te L  44  1  238  62  89 
Telefax  44  1  238  65  91 
- 21  -COMMISSION 
Secretariat  of  the Scientific  Committee  for  Food 
Commission  of  the  European  Communities 
Division III/B/2 
200  rue  de  l a  Loi 
B-1049  Brussels 
COMEU  B 21877  Telex 
Tel 
Tel efax 
32  2  235  56  51  or 235  18  15 
32  2  235  17  35 
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ANNEX  IV 
General  criteria for the use of food additives* 
1.  Food  additives  can  be  approved  only  provided  that 
there  can  be  demonstrated  a  reasonable  technological  need  and  the 
purpose  cannot  be  achieved  by  other means  which  are  economically  and 
technologically  practicable, 
they  present  no  hazard  to  health of  the  consumer  at  the  level  of  use 
proposed,  so  far  as  can  be  judged  on  the  scientific  evidence  available, 
they  do  not  mislead  the  consumer. 
2.  The  use  of  food  additives  may  be  considered only  where  there  is  evidence 
that  the  proposed  use of  the  additive  would  have  demonstrable  advantages 
of  benefit  to  the  consumer,  in other  words  it is necessary  to establish 
the  case for  what  is commonly  referred  to as  'need'.  The  use  of  food 
additives  should  serve one  or  more  of  the  purposes  set  out  from  points  (a) 
to  (d)  and  only  where  these purposes  cannot  be  achieved  by  other means 
which  are  economically  and  technologically practicable  and  do  not  present 
a  hazard  to the  health of  the  consumer  : 
(a)  to preserve  the  nutritional quality  of  the  food;  an  intentional 
reduction  in the  nutritional quality of  a  food  would  be  justified 
only  where  the  food  does  not  constitute  a  significant  item  in a 
normal  diet or  where  the  additive  is necessary  for  the  production of 
foods  for  groups  of  consumers  having  special  dietary  needs; 
(b)  to provide  necessary  ingredients  or  constituents for  foods 
manufactured  for  groups  of  consumers  having  special  dietary needs; 
(c)  to enhance  the  keeping  quality or  stability of  a  food  or  to  improve 
its organoleptic  properties,  provided  that  this  does  not  so  change 
the  nature,  substance  or quality of  the  food  as  to  deceive  the 
consumer; 
(d)  to provide  aids  in manufacture,  processing,  preparation,  treatment, 
packing,  transport  or  storage  of  food,  provided  that  the  additive is 
not  used  to disguise the  effects  of  the  use  of  faulty  raw  materials 
of  undesirable  (including  unhygienic)  practices  or  techniques, during 
the  course of  any  of  these activities. 
3.  To  assess  the  possible  harmful  effects  of  a  food  additive  or  derivatives 
thereof,  it must  be  subjected  to  appropriate toxicological  testing  and 
evaluation.  The  evaluation  should also  take  into  account,  for  example, 
any  cumulative,  synergistic  or  potentiating effect of  its use  and  the 
phenomenon  of  human  intolerance  to  substances  foreign  to  the body. 
4.  All  food  additives must  be  kept  under  continuous  observation  and  must  be 
re-evaluated  whenever  necessary  in  the  light  of  changing  conditions  of  use 
and  new  scientific  information. 
- 25  -5.  Food  additives  must  at  all times  comply  with  the  approved  criteria  of 
purity. 
6.  Approval  for  foor  additives  must  : 
(a)  specify the  foodstuffs  to  which  these  additives  may  be  added  and  the 
conditions  under  which  they  may  be  added; 
(b)  be  limited  to the  lowest  Level  of  use  necessary  to achieve  the 
desired  effect; 
(c)  take  into  account  any  acceptable  daily intake,  or  equivalent 
assessment,  established  for  the  food  additive  and  the  probable daily 
intake  of  it from  all  sources.  Where  the  food  additive  is to  be  used 
in foods  eaten by  special groups  of  consumers,  account  should  be 
taken  of  the  possible  daily  intake  of  the  food  additive  by  consumers 
in those groups. 
*  Annex  II in  COUNCIL  DIRECTIVE  89/107/EEC  of  21  December  1988  on  the 
approximation  of  the  laws  of  the  Member  States  concerning  food  additives 
authorized  for  use  in foodstuffs  intended  for  human  consumption; 
OJ  L 40  of 11.2.89,  p.  27. 
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Presentation  of an  application for assessment  of a food  additive prior to its 
authorization 
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